Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.

Saved in:
Bibliographic Details
Title: Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Authors: Dagher H; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Chaftari AM; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Subbiah IM; Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, United States., Malek AE; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Lamie P; Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Granwehr B; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., John T; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Yepez E; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Borjan J; Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, United States., Reyes-Gibby C; Emergency Medicine-Research, The University of Texas MD Anderson Cancer Center, Houston, United States., Flores M; Emergency Medicine-Research, The University of Texas MD Anderson Cancer Center, Houston, United States., Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Pande M; Gastroenterology Research, The University of Texas MD Anderson Cancer Center, Houston, United States., Ali N; Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Rojo R; Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Karp DD; Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States., Chaftari P; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States., Hachem R; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States., Raad II; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States.
Source: ELife [Elife] 2023 Feb 07; Vol. 12. Date of Electronic Publication: 2023 Feb 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.81182